|
Online Database of Chemicals from Around the World | Search | Submit | Advertise |
Home >> Chemical Listing >> Paritaprevir>> Market Analysis Reports |
Market Analysis Reports of Paritaprevir |
|
Enanta Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... with AbbVie Inc. (AbbVie), include paritaprevir and glecaprevir (ABT-493). Its ... Hepatitis C: KOL Insight ... ; Gilead) Viekira Pak/Viekirax+Exviera (paritaprevir/ ombitasvir/ dasabuvir; AbbVie/Enanta) Zepatier ... Hepatitis C Virus (HCV) - Market Insights, Epidemiology, and Market Forecast - 2030 ... (ledipasvir/sofosbuvir), Viekira Pak (ombitasvir/paritaprevir/ritonavir tablets; dasabuvir tablets), and ... and sofosbuvir), Viekira Pak (ombitasvir, paritaprevir, and ritonavir tablets; dasabuvir tablets ... Global Hepatitis Drugs Market – Drivers, Opportunities, Trends, and Forecasts: 2017–2023 Overview: Hepatitis is a medical condition where the liver is predominantly affected, which can also affect the digestive system and brain. There are three major types of hepatitis condition – HAV, HBV, and HCV. HCV is a major public health problem that ... NPS+ Hepatitis C Virus (HCV) Infection US [2018] ... (sofosbuvir; Gilead) Viekira Pak (ombitasvir/paritaprevir/ritonavir; AbbVie) Zepatier (elbasvir/grazoprevir ... NPS+ Hepatitis C Virus (HCV)Infection (EU5) [2018] ... ) Sovaldi (sofosbuvir; Gilead) Viekirax (ombitasvir/paritaprevir/ritonavir; AbbVie) Zepatier (elbasvir/grazoprevir ... Physician Views: And then there were two – will AbbVie's 3-DA regimen prove a compelling competitor to Gilead's Harvoni? ... 's oral '3-DA' product - comprising Viekirax (ombitasvir/ paritaprevir/ ritonavir) plus Exviera (dasabuvir) - for ... Hepatitis C: Update Bulletin [February 2016] ... think of AbbVie’s Viekira Pak (ombitasvir, paritaprevir and ritonavir tablets co-packaged with ... about AbbVie’s Viekira Pak (ombitasvir, paritaprevir and ritonavir tablets co-packaged with ... |